Happy news to announce this morning: we just closed our second fundraising from new and existing investors 😉👌
It’s a major milestone for the development of Labiotech.eu as it will allow us to continue investing in amazing content, launch new products and grow our revenues. Thanks to the team for their amazing work and for making that fundraising possible! And now, here’s the press release (link to the French and German press release after it):
September 18th 2017, The Berlin-based startup Labiotech.eu announces that it has raised a 6-figure seed-round from new lead investor Wille AG from Zurich and 3 new business angels, Indiana Capital, JOT-Berlin and Iduskia, as well as existing investors, WestTech Ventures and 3 previous business angels.
Labiotech.eu was founded three years ago and has grown rapidly, tripling its visitors, since the first fundraising 18 months ago. It now welcomes nearly 100k monthly visitors and counts five of the largest life sciences companies as customers. This makes it the largest biotech platform in Europe, propelled by a team of 14 biotech enthusiasts.
The whole team believes biotech is an industry that has an enormous impact on making the world a better place through the development of cutting-edge and life-saving technologies, and that biotech information is not as accessible as it should be. Labiotech.eu is a platform providing digital information on the biotech ecosystem and its players, with topics such as innovation, investments, partnerships, discoveries and more.
This new round of capital will support Labiotech.eu’s growth and offer the team more resources for the creation of content and the launch of new products for their readers and clients.
“We’re thankful to our existing and new investors for their belief in our mission and for helping us to change how people are informed about biotech,” said Philip Hemme and Joachim Eeckhout, founders of Labiotech.eu.
“The team at Labiotech.eu has impressed us in the last 18 months and we are very happy to continue to work with them to support their vision,” commented Alexander Koelpin, MD & Partner WestTech Ventures.
First fundraising: https://tech.eu/brief/labiotech-seed-funding/
Why is one of the most successful biotech entrepreneur in Europe reading Labiotech.eu: https://www.labiotech.eu/curevac-ingmar-hoerr-reading-labiotech-eu/
German press release: https://drive.google.com/file/d/0B2i8mWAnWHqCdEV1azZjVTBQb28/
French press release: https://drive.google.com/file/d/0B2i8mWAnWHqCeEU3bmtFdG5kNDg/
Please feel free to reach out to me at philip-at-www.labiotech.eu if you need anything else 😉